VECTUS BIOSYSTEMS LIMITED — Board/Management Information 2016

Oct 19, 2016

==> picture [149 x 67] intentionally omitted <==

20 October 2016

Company Announcements Office Australian Securities Exchange

Change to the Board of Directors

Vectus Biosystems Limited (ASX:VBS) advises that Non-Executive Director Mr Bernard Stang has resigned from the Board of the Company, after being a Director of Vectus for 11 years. His resignation is effective from 28 October 2016. The Board thanks him for his contribution and service to the Company since his appointment as a Director on 12 December 2005.

Attached is Mr B Stang’s Appendix 3Z.

In May 2016 Vectus appointed Dr Susan Pond to the Board as a Non-Executive Director. She has extensive industry experience. The Company has commenced the process of identifying potential future Directors to aid in the next stage of commercialising its technology.

Vectus Biosystems Limited

Robert J Waring Company Secretary

VECTUS BIOSYSTEMS LIMITED ABN 54 117 526 137

3-11 Primrose Avenue, Rosebery, NSW 2018 Telephone: +61 2 9662 4144 Facsimile: +61 2 9697 0933 Website: www.vectusbiosystems.com.au

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Vectus Biosystems Limited (ASX:VBS) ABN 54 117 526 137

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Bernard Stang
Date of last notice	26 February 2016
Date that director ceased to be director	28 October 2016

Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

2,550,000 fully paid ordinary shares, escrowed until 23 February 2018.

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

	Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest Mr Bernard Stang & Mr Maurie Stang Bernard Stang and Maurie Stang are 50% each shareholders and beneficiaries of the trust Medi- Consumables S/F A/C. Bernard Stang and Maurie Stang are 50% each shareholders of each of the following companies: Stangcorp Pty Ltd Epitek Corporation Pty Ltd 247 Church Street Pty Ltd	Number & class of securities 1,500 fully paid ordinary shares 1,500 fully paid ordinary shares 1,500 fully paid ordinary shares 1,500 fully paid ordinary shares

• See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Brunswick Property Pty Ltd Ramlist Pty Ltd Regional Health Care Group Pty Ltd Teknik Pty Ltd	1,500 fully paid ordinary shares 1,500 fully paid ordinary shares 1,500 fully paid ordinary shares 1,500 fully paid ordinary shares

Part 3 – Director’s interests in contracts

Part 3 – Director’s interests in contracts
Detail of contract	Not Applicable
Nature of interest	Not Applicable
Name of registered holder (if issued securities)	Not Applicable
No. and class of securities to which interest relates	Not Applicable

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002